The Board of Directors of Gujarat Kidney and Superspeciality Limited approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, at their meeting held on May 28, 2026. The company reported a standalone revenue from operations of Rs 924.32 Lacs for the quarter ended March 31, 2026, compared to Rs 976.45 Lacs in the previous quarter and Rs 801.62 Lacs in the corresponding quarter of the previous year. The standalone profit after tax for the quarter stood at Rs 136.78 Lacs, compared to Rs 233.26 Lacs in the previous quarter and Rs 126.48 Lacs in the same period last year.

Gujarat Kidney and Superspeciality Limited is a healthcare provider that operates a network of hospitals and healthcare facilities, specializing in renal care and superspeciality services. The company has expanded its operational footprint through various subsidiaries, including Harmony Medicare Private Limited, Parekh’s Hospital Private Limited, and other subsidiary firms, to provide comprehensive medical care. As of May 2026, the company continues to focus on strengthening its healthcare infrastructure and service delivery across its locations in Gujarat. There are no details regarding famous investors in the provided notices.